Indoco Remedies surges on plan to invest Rs 125 crore for business expansion

31 Jul 2015 Evaluate

Indoco Remedies is currently trading at Rs 338.95, up by 10.95 points or 3.34% from its previous closing of Rs 328.00 on the BSE.

The scrip opened at Rs. 331.15 and has touched a high and low of Rs. 342.95 and Rs. 331.00 respectively. So far 8768 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 413.10 on 25-May-2015 and a 52 week low of Rs. 213.00 on 14-Aug-2014.

Last one week high and low of the scrip stood at Rs. 373.95 and Rs. 325.00 respectively. The current market cap of the company is Rs. 3105.47 crore.

The promoters holding in the company stood at 59.25% while Institutions and Non-Institutions held 19.29% and 21.46% respectively.

Indoco Remedies is planning to invest Rs 125 crore for expansion of its sterile ophthalmic facility at Goa and for setting up a greenfield API facility at Patalganga in Maharashtra. The investment will also cover an additional pilot plant for finished dosages at Goa.

Further, the company will continue to launch around 20 new products every year. The company has re-structured the marketing divisions to sharpen the pattern of coverage of different doctor specialities and have added around 500 MRs, taking the total MR strength to 2800.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

251.25 -0.65 (-0.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×